Welcome, please sign in
Follow DJO on Facebook Follow DJO on Twitter
Grand Rounds
  Most Recent Cases
  Dates of Case
  Type of Case
  Submit a Grand Round.
  Register with DJO to receive personalized updates.

If you're already a
member, please sign in.
A 24-year-old woman with rapidly progressing vision loss
Digital Journal of Ophthalmology 2017
Volume 23, Number 1
January 15, 2017
DOI: 10.5693/djo.03.2016.10.001
Printer Friendly

Download PDF



Milad Modabber, MD, MSc | Department of Ophthalmology, McGill University, Montreal, Quebec, Canada
Vasudha Gupta MD, FRCSC | Department of Ophthalmology, Queen’s University, Kingston, Ontario, Canada
Amadeo R. Rodriguez, MD | Department of Surgery Ophthalmology and Medicine Neurology, McMaster University, Hamilton, Ontario, Canada
References
1. Friedman DI, Jacobson DM. Idiopathic intracranial hypertension. J Neuro-ophthalmol 2004;24:138-45.
2. Durcan FJ, Corbett JJ, Wall M. The incidence of pseudotumor cerebri. Population studies in Iowa and Louisiana. Arch Neurol 1988;45:757-7.
3. Thambisetty M, Lavin PJ, Newman NJ, Biousse V. Fulminant idiopathic intracranial hypertension. Neurology 2007;68;229-32.
4. Friedman DI, Liu Gt, Digre KB: Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology 2013;81:1159-65.
5. Rush JA. Pseudotumor cerebri. Clinical profile and visual outcome in 63 patients. Mayo Clin Proc 1980;55:541-6.
6. Corbett JJ, Savino PJ, Thompson HS, et al. Visual loss in pseudotumor cerebri. Follow-up of 57 patients from five to 41 years and a profile of 14 patients with permanent severe visual loss. Arch Neurol 1982;39:461-74.
7. Heckmann JG, Stefan H, Groh MJ, Winterholler M, Neundörfer B. A rare cause of acute vision loss: pseudotumor cerebri: case report of course with recurrence after decompression of the optic nerve [in German]. Nervenarzt 1998;69:702-6.
8. Kidron D, Pomeranz S. Malignant pseudotumor cerebri: report of two cases. J Neurosurg 1989;71:443-5.
9. Groh MJ, Jünemann A. Papilledema and acute loss of vision in a patient with pseudotumor cerebri [in German]. Klin Monat Augenheilkunde 1999;215:315-8.
10. Pollock SC. Acute papilledema and visual loss in a patient with pseudo- tumor cerebri. Arch Ophthalmol 1987;105:752-3.
11. Malomo AO, Idowu OE, Shokunbi MT, Nwaorgu OG, Oluleye TS. Non-operative management of benign intracranial hypertension presenting with complete visual loss and deafness. Pediatr Neurosurg 2006;42:62-4.
12. Liu GT, Volpe NJ, Schatz NJ, Galetta SL, Farrar JT, Raps EC. Severe sudden visual loss caused by pseudotumor cerebri and lumboperitoneal shunt failure. Am J Ophthalmol 1996;122:129-31.
13. Liu GT, Glaser JS, Schatz NJ. High-dose methylprednisolone and acetazolamide for visual loss in pseudotumor cerebri. Am J Ophthalmol 1994;118:88-96.
14. Lee AG, Wall M. Papilledema: Are we any nearer to a consensus on pathogenesis and treatment? Curr Neurol Neurosci Rep 2012;12:334-9.
15. Digre KB, Corbett JJ. Idiopathic intracranial hypertension (pseudotumor cerebri): a reappraisal. Neurologist 2001;7:2-67.
16. Curry WT Jr, Butler WE, Barker FG II. Rapidly rising incidence of cerebrospinal fluid shunting procedures for idiopathic intracranial hypertension in the United States, 1988-2002. Neurosurgery 2005;57:97-108.
17. Ahmed R, Friedman DI, Halmagyi GM. Stenting of the transverse sinuses in idiopathic intracranial hypertension. J Neuro-Ophthalmol 2011;31:374-80
18. Lueck C, McIlwaine G. Interventions for idiopathic intracranial hypertension. Cochrane Database Syst Rev 2005(3):CD003434.
19. Brazis PW. Clinical review: the surgical treatment of idiopathic pseudotumour cerebri (idiopathic intracranial hypertension). Cephalalgia 2008;28:1361-73.
20. Spitze A, Malik A, Al-Zabudi N, Golnik K, Lee AG: Optic nerve sheath fenestration vs cerebrospinal diversion procedures: what is the preferred surgical procedure for the treatment of idiopathiv intracranial hypertension failing maximum medical therapy? J Neuro-Ophthalmol 2013;33:183-8.
21. Uretsky S. Surgical interventions for idiopathic intracranial hypertension. Curr Opin Ophthalmol 2009;20:451-5.
top